Search for: "ACTAVIS" Results 781 - 800 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Mar 2011, 10:00 pm by Adam Schlossman
Mensing (09-993) consolidated with Actavis v. [read post]
22 Mar 2011, 4:21 pm by Marie Louise
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly…  well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany: Düsseldorf… [read post]
16 Mar 2011, 3:50 am by Marie Louise
Actavis (Kluwer Patent Blog) Valsartan – Norway: Valsartan case goes on appeal: Novartis v Actavis (The SPC Blog) Xeloda (Capecitabine) – US: Hoffmann-La Roche files patent infringement complaint against Accord following Para IV challenge (Patent Docs) [read post]
14 Mar 2011, 11:12 am by Tom Lamb
  Now, however, Actavis and Pliva are arguing that federal law does preempt lawsuits for failing to warn of the dangers which involve generic drugs, and thereby immunizes those generic drug companies from any legal liability for the drug side effect which Ms. [read post]
9 Mar 2011, 3:00 am by Marie Louise
Allergan, Inc (Chicago IP Litigation Blog) Synagis (Palivizumab) – US: PDL BioPharma settles Medimmune Synagis litigation for $93M (Patent Docs) TriCor (Fenofibrate) – US: Abbott and Elan end TriCor suit with Ranbaxy (Patent Docs) Valsartan – Norway: Oslo District Court holds Actavis’ Valsartan/HCTZ product infringes Novartis’ patent covering synthesis route for Valsartan; deals inter alia with scope of Valsartan SPC (The SPC Blog) [read post]
24 Feb 2011, 1:49 pm by Bexis
Actavis Totowa, LLC, 2010 WL 3604674, at *3-4 (S.D. [read post]
15 Feb 2011, 5:26 pm by Marie Louise
(FDA Law Blog) Diovan (Vasartan) – France: Novartis v Actavis – preliminary injunction for Valsartan confirmed (The SPC Blog) Diovan HTC (Valsartan) – Belgium: Antwerp Court of Appeal stops infringement of Valsartan/HCTZ SPC based on patent claiming Valsartan alone: Novartis v Teva (The SPC Blog) Lescol (Fluvastatin) – US: Novartis files patent infringement complaint against Mylan following Para IV challenge (Patent Docs) (GenericsWeb) Mucinex (Guaifenesin) –… [read post]
8 Feb 2011, 10:51 pm by Marie Louise
(FDA Law Blog) US: Another academic with solutions to problems that don’t exist (Patent Docs) US: Syngenta files for declaratory judgment of invalidity and non-infringement of Bayer’s patents based on its development of GM crops containing HPPD gene (Patent Docs) US: District Court New Jersey: Loss of market share to infringing competitor during six year reexamination warrants denial of stay: Wyeth et al v Abbott (Docket Report) US: District Court New Jersey: Court precludes jury… [read post]
26 Jan 2011, 11:46 am by Will
We’re all curious to see what the Supreme Court does with the generic prescription drug manufacturers’ preemption defense in Actavis Elizabeth, LLC v. [read post]
24 Jan 2011, 8:19 pm by Josh Myers
Court of Appeals made the decision that Actavis, Inc., an Icelandic company, could be sued by, Julie Demahy, a woman who claims she was not properly warned about the risks of the drug by the drug company. [read post]
11 Jan 2011, 11:07 pm by Kelly
Senators follow House colleagues in making BPCIA exclusivity clarifications; New study suggests benefits of longer drug exclusivity period (FDA Law Blog) US: BPCIA’s principal authors seek to clarify Congressional intent with respect to 12-year exclusivity period; PhRMA/BIO request ‘umbrella exclusivity’ (FDA Law Blog) US: BIO’s IP priorities for 2011 (PatentlyBIOtech) US: BIO survey shows support for DNA-based patents despite some reservations (Patent Docs) US:… [read post]
22 Dec 2010, 3:01 am by Kelly
Actavis Elizabeth LLC et al (Patent Docs) Solodyn (Minocycline) – US: Patent infringement complaint filed following a Paragraph IV certification: Medicis Pharmaceutical Corp. v. [read post]